Integrated Diagnostics Holdings PLC 2025 IR
The report details the financial and operational performance of Integrated Diagnostics Holdings plc (IDH) for the fiscal year 2025. The company achieved record revenues of EGP 7.9 billion, representing a 37% year-on-year increase, driven by test volume growth and strategic pricing. Key milestones included the acquisition of Cairo Ray for Radiotherapy in Egypt and expanding operations in Saudi Arabia. IDH also advanced its sustainability agenda by publishing its fourth TCFD-aligned disclosure and expanding its Scope 1 and Scope 2 greenhouse gas emissions inventory across Egypt and Jordan.
Company: Integrated Diagnostics Holdings PLC
Sector: Health Care
Country: Jersey
Year: 2025
Type: IR
Pages: 100
Integrated Diagnostics Holdings PLC
Annual Report
The report details the financial and operational performance of Integrated Diagnostics Holdings plc (IDH) for the fiscal year 2025. The company achieved record revenues of EGP 7.9 billion, representing a 37% year-on-year increase, driven by test volume growth and strategic pricing. Key milestones included the acquisition of Cairo Ray for Radiotherapy in Egypt and expanding operations in Saudi Arabia. IDH also advanced its sustainability agenda by publishing its fourth TCFD-aligned disclosure and expanding its Scope 1 and Scope 2 greenhouse gas emissions inventory across Egypt and Jordan.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Women on Board
Women in Management
Net Zero Target
Employees